Laboratorios Kendrick

Laboratorios Kendrick is a prominent Mexican pharmaceutical company that specializes in the production and distribution of generic medications. Established in 1946, the company has built a comprehensive portfolio of affordable healthcare products across various therapeutic categories, including analgesics, antibiotics, and cardiovascular treatments. In 2008, Kendrick was acquired by the Swiss pharmaceutical group Nycomed, which was later integrated into Takeda Pharmaceutical Company in 2011. Currently, Kendrick serves as a strategic brand within Takeda's Mexican operations, leveraging its local manufacturing capabilities to supply the regional market with high-quality essential medicines. The company's long-standing reputation in Mexico makes it a key asset for Takeda's growth in the Latin American generics sector.